Volume 18, Issue 2 pp. 142-149
Original Article

Early protocol biopsies in pediatric renal transplantation: Interest for the adaptation of immunosuppression

Alexandra Bruel

Alexandra Bruel

Department of Pediatrics, Nantes University Hospital, Nantes, France

Search for more papers by this author
Emma Allain-Launay

Emma Allain-Launay

Department of Pediatrics, Nantes University Hospital, Nantes, France

Search for more papers by this author
Julie Humbert

Julie Humbert

Department of Pediatrics, Nantes University Hospital, Nantes, France

Search for more papers by this author
Amélie Ryckewaert

Amélie Ryckewaert

Department of Pediatrics, Rennes University Hospital, Rennes, France

Search for more papers by this author
Gérard Champion

Gérard Champion

Department of Pediatrics, Angers University Hospital, Angers, France

Search for more papers by this author
Anne Moreau

Anne Moreau

Department of Anatomopathology, Nantes University Hospital, Nantes, France

Search for more papers by this author
Karine Renaudin

Karine Renaudin

Department of Anatomopathology, Nantes University Hospital, Nantes, France

Search for more papers by this author
Georges Karam

Georges Karam

Department of Urology and Renal Transplantation, Nantes University Hospital, Nantes, France

Search for more papers by this author
Gwenaelle Roussey-Kesler

Corresponding Author

Gwenaelle Roussey-Kesler

Department of Pediatrics, Nantes University Hospital, Nantes, France

Gwenaelle Roussey-Kesler, Clinique Medicale Pediatrique, Hopital Mère enfants, Centre Hospitalier Universitaire, Quai Moncousu, 44093 Nantes, France

Tel.: +33 2 40 08 36 60

Fax: +33 2 40 08 36 65

E-mail: [email protected]

Search for more papers by this author
First published: 16 December 2013
Citations: 7

Abstract

GPB are often performed in PRT to detect subclinical acute rejection or IF/TA. Reducing immunosuppression side effects without increasing rejection is a major concern in PRT. We report the results of GPB in children transplanted with a steroid-sparing protocol adapted to immunological risk. Children under 18 yr who received a renal transplantation between April 1, 2009 and May 31, 2012 were included. Immunosuppression consisted of an antibody induction therapy, tacrolimus, and MMF for all recipients. CSs were administered to children under five yr old, or receiving a second allograft. Twenty-eight children were included, 50% were CSs free. GPB were performed between three and six months. IF/TA was documented in seven biopsies; four of these seven children were CS free. One child, with CSs, presented a borderline rejection, and another child, steroid free, with significant inflammatory interstitial infiltrate, considered as a subclinical rejection, was treated with CSs pulses. The median eGFR was stable (74, 67.5, and 82 mL/min/1.73 m² at, respectively, seven days, three months, and one yr). Patient and graft survival were 100%. These results have to be confirmed in a larger cohort, with long-term follow-up.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.